Abbott Lowers 2026 Comparable Sales-Growth Outlook to About 6%

The planned spin-off would distribute shares to Abbott shareholders, with a close targeted by the end of 2027 pending approvals, an effective Form 10 registration statement and final board approval.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.